Around 200 million doses of COVID-19 vaccine have been administered so far inside China, with an emphasis on front-line workers, university students and people living in border areas, health officials said.
China is ramping up vaccination efforts after a slow start that was due in part to the virtual elimination of domestic transmission of the coronavirus. Just two local cases were reported on Wednesday, both in the city of Ruili, which borders on Myanmar.
Just six new cases were reported on Thursday, all of them imported, while testing continued in Ruili, where China’s latest outbreak appears to have been contained.
China has approved five domestically produced vaccines and exported millions of doses, although some scientists believe they provide less protection than those by Pfizer, Moderna and AstraZeneca. The Chinese vaccines have an efficacy range of 50.7% to 79.3%, based on company data, lower than their foreign peers but still effective.
Read original article